FOMX - Foamix Pharmaceuticals Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue3,5953,6695,527849
Cost of Revenue-135970
Gross Profit3,5953,6565,468779
Operating Expenses
Research Development63,70257,13425,53910,680
Selling General and Administrative14,78512,1369,5797,029
Non Recurring----
Others----
Total Operating Expenses78,48769,28335,17717,779
Operating Income or Loss-74,892-65,614-29,650-16,930
Income from Continuing Operations
Total Other Income/Expenses Net9411,063701452
Earnings Before Interest and Taxes-74,892-65,614-29,650-16,930
Interest Expense---243-243
Income Before Tax-73,951-64,551-28,949-16,478
Income Tax Expense2121,16438739
Minority Interest----
Net Income From Continuing Ops-74,163-65,715-29,336-16,517
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-74,163-65,715-29,336-16,517
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-74,163-65,715-29,336-16,517